Discovery of Novel Fedratinib-Based HDAC/JAK/BRD4 Triple Inhibitors with Remarkable Antitumor Activity against Triple Negative Breast Cancer
Chunlong Zhao(University of Groningen), Yi‐Chao Zheng(Ministry of Education), Shunda Li(Xinjiang University), Jin’ge Zhang(Shandong University), Mengzhe Li(Shandong University), Jintao Li(Beijing Normal University), Yu Zhang(Wannan Medical College), Yinping Geng(Shandong University), Hongwei Meng(Shandong University), Qipeng Chai(Shandong University), Fengling Liu(Nanjing University of Information Science and Technology), Meng-Yang Liu(Gansu University of Traditional Chinese Medicine)
Cited by 24
Related Papers
Strategic adjustment of land use policy under the economic transformation
|Land Use Policy|2018|592
Etiological and epidemiological features of acute respiratory infections in China
|Nature Communications|2021|530
Exosomes derived from mesenchymal stem cells reverse EMT via TGF-β1/Smad pathway and promote repair of damaged endometrium
|Stem Cell Research & Therapy|2019|294
Triazole–Dithiocarbamate Based Selective Lysine Specific Demethylase 1 (LSD1) Inactivators Inhibit Gastric Cancer Cell Growth, Invasion, and Migration
|Journal of Medicinal Chemistry|2013|221